Abliva AB (publ) (NEVPF)
USD 0.04
(0.0%)
USD 0.04
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -770.05 Thousand | -15.23 Million | -12.55 Million | -8.22 Million | -7.73 Million | -7.19 Million |
| Net Income | -9.42 Million | -8.14 Million | -13.59 Million | -7.3 Million | -8.22 Million | -7.71 Million |
| Depreciation & Amortization | 181.01 Thousand | 249.25 Thousand | 292.86 Thousand | 311.47 Thousand | 62.7 Thousand | 26.84 Thousand |
| Deferred income taxes | - | -942.74 Thousand | -268.45 Thousand | - | - | - |
| Stock-based compensation | 1.21 Million | 551 Thousand | 415 Thousand | - | - | - |
| Change in working capital | 7.51 Million | -7.67 Million | 688.23 Thousand | -1.23 Million | 235.87 Thousand | 499.21 Thousand |
| Other non-cash items | 1.59 Million | 724.08 Thousand | -90.83 Thousand | -609.00 | 190.89 Thousand | -362.17 Thousand |
| Investing Cash Flow | -127.32 Thousand | -86.42 Thousand | -119.89 Thousand | -171.32 Thousand | -287.89 Thousand | -436.73 Thousand |
| Investments in PPE | -127.32 Thousand | -86.42 Thousand | -119.89 Thousand | -171.32 Thousand | -287.89 Thousand | -436.84 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | 112.79 |
| Other Investing Activities | -127.92 Thousand | -84.53 Thousand | -113.2 Thousand | -171.02 Thousand | -280.4 Thousand | -427.6 Thousand |
| Financing Cash Flow | 40.86 Thousand | 19.52 Million | 8.34 Million | 8.8 Million | 11.48 Million | 7.29 Million |
| Debt repayment | -33.51 Thousand | -2.3 Million | -10.17 Thousand | -32.69 Thousand | -32.99 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 74.22 Thousand | 17.22 Million | 8.35 Million | 8.83 Million | 11.51 Million | 7.29 Million |
| Other Financing Activities | -33.36 Thousand | 2.29 Million | -8367.00 | -32.75 Thousand | -33 Thousand | 7.29 Million |
| Accounts receivables | - | - | - | 10.47 Thousand | 115.05 Thousand | - |
| Accounts payables | -275.07 Thousand | 106.76 Thousand | 732.27 Thousand | -1.24 Million | 120.81 Thousand | 402.33 Thousand |
| Inventory | - | - | - | -10.47 Thousand | - | - |
| Other working capital | 7.78 Million | -7.78 Million | -44.04 Thousand | 10.47 Thousand | 235.77 Thousand | 96.88 Thousand |
| Cash at beginning of period | 6.34 Million | 2.45 Million | 7.5 Million | 6.22 Million | 2.92 Million | 3.54 Million |
| Cash at end of period | 5.69 Million | 6.34 Million | 2.45 Million | 7.5 Million | 6.22 Million | 2.92 Million |
| Capital Expenditure | -127.32 Thousand | -86.42 Thousand | -119.89 Thousand | -171.32 Thousand | -287.89 Thousand | -436.84 Thousand |
| Effect of forex changes on cash | -50 Thousand | 101 Thousand | 68 Thousand | -6000.00 | 4000.00 | 5000.00 |
| Net cash flow / Change in cash | -648.99 Thousand | 3.88 Million | -5.04 Million | 1.27 Million | 3.3 Million | -613.93 Thousand |
| Free Cash Flow | -897.38 Thousand | -15.32 Million | -12.67 Million | -8.39 Million | -8.02 Million | -7.63 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.41 Million | -1.69 Million | -2.49 Million | -9.42 Million | -3 Million | -1.95 Million |
| Depreciation & Amortization | 46.01 Thousand | 45.29 Thousand | 47.47 Thousand | 181.01 Thousand | 777.02 Thousand | 65.9 Thousand |
| Deferred income taxes | - | - | - | - | -1.93 Million | 81.34 Thousand |
| Stock-based compensation | 91 Thousand | 283 Thousand | 327 Thousand | 1.21 Million | 327 Thousand | 346 Thousand |
| Change in working capital | -46.76 Thousand | -845.27 Thousand | 2.44 Million | 7.51 Million | 1.74 Million | 2.24 Million |
| Other non-cash items | 263.95 Thousand | 750.65 Thousand | -271.12 Thousand | 1.59 Million | 1.64 Million | -389.69 Thousand |
| Investing Cash Flow | -35.86 Thousand | -7658.80 | -94.55 Thousand | -127.32 Thousand | -10.76 Thousand | -13.75 Thousand |
| Investments in PPE | -35.86 Thousand | -7658.80 | -94.55 Thousand | -127.32 Thousand | -10.76 Thousand | -13.75 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -382 Thousand | - | -95 Thousand | -127.92 Thousand | -10.8 Thousand | -13.9 Thousand |
| Financing Cash Flow | 3.76 Million | -8592.80 | -15.98 Thousand | 40.86 Thousand | -7752.00 | 13.01 Thousand |
| Debt repayment | - | - | -8627.46 | -33.51 Thousand | -7780.36 | -7788.10 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -7437.47 | - | - | - |
| Common Stock Issuance | 3.77 Million | - | -7402.50 | 74.22 Thousand | - | 20.76 Thousand |
| Other Financing Activities | -8826.60 | - | -8586.50 | -33.36 Thousand | - | -7753.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -161.88 Thousand | -626.62 Thousand | 386.7 Thousand | -275.07 Thousand | -56.63 Thousand | 559.15 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 115.12 Thousand | -218.64 Thousand | 2.06 Million | 7.78 Million | 1.8 Million | 1.68 Million |
| Cash at beginning of period | 2.9 Million | 5.69 Million | 5.34 Million | 6.34 Million | 5.88 Million | 5.7 Million |
| Cash at end of period | 4.24 Million | 2.9 Million | 5.69 Million | 5.69 Million | 5.34 Million | 5.88 Million |
| Capital Expenditure | -35.86 Thousand | -7658.80 | -94.55 Thousand | -127.32 Thousand | -10.76 Thousand | -13.75 Thousand |
| Effect of forex changes on cash | 13 Thousand | 55 Thousand | -105 Thousand | -50 Thousand | 14 Thousand | 39 Thousand |
| Net cash flow / Change in cash | 1.33 Million | -2.78 Million | 343.74 Thousand | -648.99 Thousand | -538.27 Thousand | 178.19 Thousand |
| Free Cash Flow | -2.44 Million | -2.47 Million | -69.68 Thousand | -897.38 Thousand | -461.74 Thousand | 375.84 Thousand |
LFLO
SOBA
300719
FKYS
300504
300519